Literature DB >> 9367409

Specificities of anti-neutrophil autoantibodies in patients with rheumatoid arthritis (RA).

J Brimnes1, P Halberg, S Jacobsen, A Wiik, N H Heegaard.   

Abstract

The objective of this study was to characterize antigens recognized by neutrophil-specific autoantibodies from patients with RA. Sera from 62 RA patients were screened by indirect immunofluorescence (IIF). Positive sera were further tested by ELISAs for antibodies against various granule proteins and by immunoblotting of electrophoretically separated cell, granule or nuclear extracts. Forty-two sera (68%) reacted with ethanol-fixed neutrophils. In the ELISAs 32% of the 28 medium to strongly IIF-positive sera were negative, while 43% were weakly positive for more than one antigen. Immunoblots of whole neutrophils showed IgG reactions at 25-35 kD, in the 55-kD region, at 80 kD, and at 110 kD. Most sera reacted with more than one band. Except for the 55-kD antigen, none of the antigens appeared in lymphocytes. The most notable reactivity in subcellular fractions was with lactoferrin and with bands of 25-35 kD from nuclei. In conclusion, anti-neutrophil autoantibodies from RA patients recognize different antigens in the cytoplasm and in the nucleus. Lactoferrin is one of the common antigens recognized, but also unknown nuclear antigens of 25-35 kD mol. wt are involved.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367409      PMCID: PMC2265490          DOI: 10.1111/j.1365-2249.1997.tb08324.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  AN ANTINUCLEAR FACTOR SPECIFIC FOR LEUCOCYTES.

Authors:  V FABER; P ELLING; G NORUP; B MANSA; N I NISSEN
Journal:  Lancet       Date:  1964-08-15       Impact factor: 79.321

2.  Delineation of a standard procedure for indirect immunofluorescence detection of ANCA.

Authors:  A Wiik
Journal:  APMIS Suppl       Date:  1989

3.  Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis.

Authors:  W Hassfeld; G Steiner; K Hartmuth; G Kolarz; O Scherak; W Graninger; N Thumb; J S Smolen
Journal:  Arthritis Rheum       Date:  1989-12

4.  The new ACPA/ANCA nomenclature.

Authors:  A Wiik; F J van der Woude
Journal:  Neth J Med       Date:  1990-04       Impact factor: 1.422

Review 5.  Granulocyte-specific antinuclear antibodies. Possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis.

Authors:  A Wiik
Journal:  Allergy       Date:  1980-06       Impact factor: 13.146

6.  Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase.

Authors:  J L Niles; R T McCluskey; M F Ahmad; M A Arnaout
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

7.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

8.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.

Authors:  R J Falk; J C Jennette
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

9.  Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation.

Authors:  N Borregaard; J M Heiple; E R Simons; R A Clark
Journal:  J Cell Biol       Date:  1983-07       Impact factor: 10.539

10.  Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme.

Authors:  J Lüdemann; B Utecht; W L Gross
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Methods for the detection of anti-neutrophil cytoplasmic antibodies. Recommendations for clinical use of ANCA serology and laboratory efforts to optimize the informative value of ANCA test results.

Authors:  A Wiik
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Churg-Strauss syndrome.

Authors:  M Conron; H L Beynon
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

3.  Antineutrophil cytoplasmic antibodies in Bulgarian patients with rheumatoid arthritis: characterization and clinical associations.

Authors:  Irena Manolova; Maria Dantcheva
Journal:  Rheumatol Int       Date:  2004-11-11       Impact factor: 2.631

4.  Naturally occurring anti-band 3 antibodies in clearance of senescent and oxidatively stressed human red blood cells.

Authors:  Hans U Lutz
Journal:  Transfus Med Hemother       Date:  2012-08-27       Impact factor: 3.747

5.  Characterisation of autoantibodies to neutrophil granule constituents among patients with reactive arthritis, rheumatoid arthritis, and ulcerative colitis.

Authors:  H Locht; T Skogh; A Wiik
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

6.  Does searching for antineutrophil cytoplasmic antibodies help with the diagnosis of Adult-onset Still's disease?

Authors:  Massoud Saghafi; Maryam Sahebari
Journal:  Rheumatol Int       Date:  2012-03-31       Impact factor: 2.631

7.  High prevalence of autoantibodies among Danish centenarians.

Authors:  K Andersen-Ranberg; M HØier-Madsen; A Wiik; B Jeune; L Hegedus
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

Review 8.  Autoantibodies in vasculitis.

Authors:  Allan Wiik
Journal:  Arthritis Res Ther       Date:  2003-04-09       Impact factor: 5.156

9.  MPO-ANCA-associated necrotizing glomerulonephritis in rheumatoid arthritis; a case report and review of literature.

Authors:  Mário Góis; Ana Messias; Dulce Carvalho; Fernanda Carvalho; Helena Sousa; João Sousa; Fernando Nolasco
Journal:  J Nephropathol       Date:  2016-10-27

Review 10.  Citrullination in Rheumatoid Arthritis-A Process Promoted by Neutrophil Lysis?

Authors:  Tal Gazitt; Christian Lood; Keith B Elkon
Journal:  Rambam Maimonides Med J       Date:  2016-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.